More details about
the great lineup of our Presenters -
This year’s MedEdge
2013 MC is Jeff Dennis
Jeff is a noted speaker and a serial entrepreneur. Counsel and the Entrepreneur-in-Residence at Fasken Martineau DuMoulin LLP, Jeff helps high growth companies “get to the next level“ with strategic counsel and funding advice. We are delighted that he will be our guide through this year’s MedEdge Summit 2013.
John Fielding, Regional Director, Ontario Centres of Excellence will launch the 3rd MedEdge
Call for Expressions of Interest at this year’s event and discuss the successful outcomes of the previous OCE MedEdge calls.
John will also introduce an exciting OCE success story. Dr. Diana Pliurawill share her experiences of commercializing life sciences products gained over 28 years. Her most recent venture MyndTec Inc.is commercializing a groundbreaking therapy MyndMove that uses electrical stimulation to treat paralysis after stroke and spinal cord injury (SCI) patients. In clinical studies, MyndMove therapy resulted in restoration of voluntary arm and hand movement and dramatic gains in self-care independence.
The Next36 – Fostering
the Next Generation of Entrepreneurs
Partnerships between health care and start-ups and accelerators such as The Next 36 provide an excellent opportunity to develop meaningful technology to improve care delivery.
Join the discussion between Christian Lassonde, Chief Venture Advisor and Philip Chen, Co-founder, Seamless Mobile Health, Cohort of 2013, both of The Next 36, about the growing potential of mobile technology to improve patient care at lower cost. Hear why stakeholders across the health care system need to work together to build an ecosystem more ripe for innovation.
Crowd Sourcing -
the Ultimate Collaboration
Our moderator is Timothy Squire, Partner, Chair, Life Sciences Industry Group at Faskens, Martineau DuMoulin.
The panelists are Tracy Hooey, Partner, Life Sciences Group, Ingrid VanderElst, Partner,
Life Sciences Group at Fasken Martineau DuMoulin LLP and Gailina Liew, President & Chief Operating Officer of GeneNews.
The discussion is about how the new phenomenon of “crowd sourcing” can reduce costs in clinical trials and improve patient engagement, source samples, fund initiatives, study design, quality and outcomes.
Understand crowd sourcing and its use or applicability to Clinical Trials in Canada
Explore regulatory barriers to initiating life science clinical trials & research using crowd sourcing
Discuss how crowd sourcing might overcome the prohibitive costs of clinical trials and research
MedEdge 2013 will be outstanding!
Be there as high profile insiders, established start-ups and the investment community tackle today’s most pressing MedTech challenges.